R, C., MC, N., A, R., L, C., C, K., F, B., . . . ML, C. (2025). Epidemiology and economic burden of hospitalizations attributable to Respiratory Syncytial Virus (RSV) infection among infants in France, 2016 to 2023 - EPIBREATHE study. BMC infectious diseases, 25(1), 1621. https://doi.org/10.1186/s12879-025-12039-2
Chicago Style (17th ed.) CitationR, Cohen, et al. "Epidemiology and Economic Burden of Hospitalizations Attributable to Respiratory Syncytial Virus (RSV) Infection Among Infants in France, 2016 to 2023 - EPIBREATHE Study." BMC Infectious Diseases 25, no. 1 (2025): 1621. https://doi.org/10.1186/s12879-025-12039-2.
MLA (9th ed.) CitationR, Cohen, et al. "Epidemiology and Economic Burden of Hospitalizations Attributable to Respiratory Syncytial Virus (RSV) Infection Among Infants in France, 2016 to 2023 - EPIBREATHE Study." BMC Infectious Diseases, vol. 25, no. 1, 2025, p. 1621, https://doi.org/10.1186/s12879-025-12039-2.